A detailed history of Cibc Private Wealth Group, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,154 shares of ADMA stock, worth $36,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,154
Previous 9,519 77.37%
Holding current value
$36,941
Previous $106,000 59.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.21 - $20.03 $82,561 - $147,520
-7,365 Reduced 77.37%
2,154 $43,000
Q2 2024

Aug 09, 2024

SELL
$5.98 - $11.18 $62,347 - $116,562
-10,426 Reduced 52.27%
9,519 $106,000
Q1 2024

May 10, 2024

SELL
$4.4 - $6.74 $41,879 - $64,151
-9,518 Reduced 32.3%
19,945 $131,000
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $19,936 - $29,257
6,473 Added 28.16%
29,463 $133,000
Q3 2023

Nov 13, 2023

BUY
$3.47 - $4.61 $79,775 - $105,983
22,990 New
22,990 $82,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.37B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.